News About: Pharm. Industry
Tension between Handok and KPWA deepens where KPMA decides to engage
On December 4, KPMA hosts emergency board meeting and decides for aggressive measure
(The Korean Doctors’ Weekly)
Tension between Handok and Korea Pharmaceutical Wholesalers Association (KPWA) regarding the wholes...
Are Insadol and Igatan effective in curing gum?
Complaint Zero UP, which is a MBC TV program, unveiled that gum disease medicines are ineffective.
(The Korean Doctors’ weekly)
National representing gum disease medicines, Insadol and Igatan, are being questioned...
Domestic pharmaceutical industry appeals in oversea markets.
On October, The drug exports 143.92 million dollars, 18% increased vs. 2012
(Yakup Shinmoon)
Domestic pharmaceutical industry appealed to oversea markets on October.
According to the latest report of Shinhan fi...
KRPIA requested, “Reconsider of usage-price linkage system and market based Actual Transaction Price
(Yakup Shinmoon)
Korea multinational pharmaceutical industries association (KRPIA) suggested reconsidering the usage-price linkage system and marketing based Actual Transaction Price.
KRIPA requested to the min...
First training session of medical advertisement makes a great appeal to the attendees
The Korea Medical Association, Medical Advertisement Deliberative Committee hosts ‘2013 medical advertisement training session”
(Medipana)
Medical Advertisement Deliberative Committee (MADC) of the Korean Medical ...
Boryung Incorporation won a nullity suit of patent of a kinase inhibitor, ‘Gleevec’.
Generic players such as Jong-geun Dang, Dong-a Pharmaceutical Company, are going to supply their products safely stably
(Yakup shinmoon)
Boryung Inc. (President, Tae-hong Choi) won a nullity suit with Novartis of...
Smoking cessation drug, ‘Champix,’ is found to cause side effects such as nausea and more.
Ministry of Food and Drug Safety will reflect the post market surveillance results
(The Korean Doctors Weekly)
The post market surveillance results will be reflected on the permitted articles of Pfizer Korea’s Cha...
More serious polarization of pharmaceutical Industry … Main companies’ growth are continuing
Listed pharmaceutical companies’ 3 Q sales increased as 5.1%, sales profit (8.7%) and net profit (5.7%)
(Yakup shinmoon)
Pharmaceutical Industry’s polarization gets more serious.
Main companies getting profit h...
Struggle of Handok and KPWA for Margin Has Possibility of Compromise.
Handok Suggested ‘When cash payment, 1.8% of financial cost reflected.’
(Yakup shinmoon)
The struggle of Handok and the Korean Pharmaceutical Wholesales Association (KPWA) for margin can be compromised.
Accordi...
Pfizer succeeds brand power through ‘Novasc V’
Pifzer Korea launches Exforge generic and joint-promotion with Novartis will be over soon
(Dailypharm)
Pfizer Korea launched ‘Novasc V,’ which is a combination drug of Amlodipine and Valsartan.
LG Life Sciences...
